Medtronic Guardian Sensor 3 Recall for Hydroxyurea Interaction
Medtronic is recalling Guardian Sensor 3 units worldwide due to a risk of inaccurate glucose readings when used with hydroxyurea.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical device where a specific drug interaction could lead to inaccurate readings, representing a risk-of-harm product where injury has not yet been reported, fitting the High severity criteria.
Plain-English summary
Medtronic Inc. is recalling 52,196 units of the Guardian Sensor (3) (REF: MMT-7020C2) for worldwide distribution. The recall includes specific packaging configurations identified by GTINs 20763000243344 and 20763000318868. The product is intended for use with Medtronic Diabetes glucose sensing systems to continuously monitor glucose levels in persons with diabetes.
The recall is being conducted because the use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug, could result in inaccurate elevated sensor glucose readings. This interaction poses a risk of incorrect glucose monitoring for affected patients.
The recall covers all lot numbers within the active shelf life. The source text notes that the product was not distributed within the US, but the distribution pattern is listed as worldwide. Consumers and healthcare providers should stop using the affected sensors if they are actively taking hydroxyurea and consult their healthcare provider for alternative monitoring methods.
The recalled product
- Product
- Medtronic REF: MMT-7020C2 Guardian Sensor (3) for the following packaging: GS3 5PK 9L OUS2/ GTIN: 20763000243344 GS3 5PK 9L OUS2/ GTIN: 20763000318868 Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor gluc
- Manufacturer
- Medtronic Inc.
- Affected units
- 52,196
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lot numbers within active shelf life
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 20 recalled by Medtronic Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Medtronic Inc.
See all →- HighMedtronic Sphere-9 Catheter may cause ventricular fibrillation with Biotronik ICDs
FDA (Devices) · 2026-05-06
- HighVenous stents recalled over a nitinol anomaly that reduces deployed diameter
FDA (Devices) · 2026-01-21
- ModerateKidney tests recalled for distribution without premarket approval or clearance
FDA (Devices) · 2025-12-10
- HighSmartSync Patient Connector limited the window to abort high voltage therapy
FDA (Devices) · 2025-07-30
- HighCareLink SmartSync limited the window to abort a high voltage therapy
FDA (Devices) · 2025-07-30
Same hazard · inaccurate reading
See all →- HighMedtronic Guardian Sensor 3 Recall Due to Hydroxyurea Interference
FDA (Devices) · 2021-05-26
- HighMedtronic Guardian Sensor 3 Recalled for Inaccurate Glucose Readings
FDA (Devices) · 2021-05-26
- HighMedtronic Guardian Sensor 3 Recall Due to Hydroxyurea Interference
FDA (Devices) · 2021-05-26
- HighMedtronic Guardian Sensor 3 Recall Due to Hydroxyurea Interaction
FDA (Devices) · 2021-05-26
- HighMedtronic Enlite Glucose Sensor Recall Due to Hydroxyurea Interference
FDA (Devices) · 2021-05-26